BerandaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹843,50
Rentang hari
₹804,60 - ₹875,00
Rentang tahun
₹684,35 - ₹1.997,40
Kapitalisasi pasar
41,08Â M INR
Volume Rata-Rata
92,26Â rb
Rasio P/E
37,03
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,17Â M | -1,47% |
Biaya operasional | 747,93Â jt | 3,12% |
Laba bersih | 207,75Â jt | -29,41% |
Margin laba bersih | 9,56 | -28,34% |
Penghasilan per saham | — | — |
EBITDA | 257,00Â jt | -35,44% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,44Â M | 384,25% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 12,24 M | — |
Saham yang beredar | 50,67 jt | — |
Harga terhadap nilai buku | 3,49 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 3,20% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 207,75Â jt | -29,41% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Didirikan
1992
Situs
Karyawan
871
